GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (MEX:COO) » Definitions » Capital Expenditure

The Cooper (MEX:COO) Capital Expenditure : MXN-7,833.90 Mil (TTM As of Apr. 2025)


View and export this data going back to 2014. Start your Free Trial

What is The Cooper Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

The Cooper's cash flow for capital expenditures for the three months ended in Apr. 2025 was MXN-1,530 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Apr. 2025 was MXN-7,833.90 Mil.

The Cooper Capital Expenditure Historical Data

The historical data trend for The Cooper's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Capital Expenditure Chart

The Cooper Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,604.07 -4,406.13 -4,803.22 -7,085.80 -8,437.23

The Cooper Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,264.46 -1,655.18 -2,804.40 -1,844.23 -1,530.09

The Cooper Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-7,833.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (MEX:COO) » Definitions » Capital Expenditure
Comparable Companies
BAX WST ALGN SOLV HOLX ATR AVTR RGEN STVN MMSI ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
COO:USA 0I3I:UK CP60:Germany CP60:Germany C1OO34:Brazil
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
Website
https://www.coopercos.com
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.